New research into urologic conditions ? such as erectile dysfunction ? indicate that these disorders could be associated with or precursors to more serious conditions, and suggest a need for practitioners to view these diseases in the greater context of total health as opposed to isolated disorders.
Research has shown a connection between erectile dysfunction (ED) and cardiovascular disease (CVD) in men, and has established a need to consider one a precursor to the other.
If left untreated, metabolic syndrome can lead to an increased risk for diabetes mellitus and cardiovascular disease ? both known risk factors for erectile dysfunction (ED).
High levels of LDL cholesterol have been associated with a variety of health concerns, including heart disease and, most recently, prostate cancer.
The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.
Doctors at UPMC have begun a study using an investigational cardiac device, the VentrAssist? Left Ventricular Assist System (LVAD) to see whether it can be used safely and effectively in patients with end-stage heart failure.
Research shows that the prevalence of obesity is rising, causing an increase in heart disease and diabetes, among other conditions, but evidence has not yet been established linking obesity to precancerous lesions in the colon called polyps.
Millions of Americans take medications for hypertension but do not achieve control of their blood pressure. Single-tablet combinations of drugs may be what it takes to get blood pressure under control, even in people with moderate hypertension, according to results from a new international study involving more than 10,700 people with high blood pressure.
Researchers revealed that low glycemic load diet promotes more weight loss in obese and overweight individuals than low fat diets.
Researchers at the Yale University School of Medicine have found that patients with obstructive sleep apnea are at increased risk for developing of type II diabetes, independent of other risk factors.